Inversago Pharma
Micheline brings key financial expertise to Inversago, acquired all along her career in the banking industry, as well as during her tenure as Chief Financial Officer (CFO) of Locus Dialogue Inc.
Since 2002, Micheline has been working as part time CFO for small venture-backed technology startup companies. Her expertise is well-recognized throughout the biotech industry (20+ biopharmaceutical companies in her professional portfolio).
Well-versed in all aspects of financial management, she brings extensive experience in accounting, auditing, control and taxation, as well as expertise in the set-up and management of financial and IT systems, establishment of corporate policies and processes, ensuring the respect of financial laws and guidelines.
A certified general accountant, Micheline successfully completed an executive MBA at Concordia University in Montreal.
This person is not in any offices
Inversago Pharma
A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome, diabetes, obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH).